Mérieux Equity Partners

Mérieux Equity Partners (MEP) is a distinguished global investment platform headquartered in Lyon, France, with a dedicated focus on the healthcare and nutrition sectors. Leveraging its deep industry expertise and extensive network, MEP aims to support the growth and transformation of companies that are shaping the future of health and well-being. The firm manages a substantial portfolio, with over €1.5 billion in assets under management, underscoring its significant presence and capacity within its specialized markets.

MEP's investment strategy spans various stages, primarily concentrating on growth capital and buyout opportunities, while also engaging in venture capital through strategic partnerships. Their flagship Mérieux Participations funds, such as the recently closed Mérieux Participations 4 (MP4) at €525 million, target both minority and majority stakes in small and mid-cap companies across Europe and North America. Beyond direct equity, MEP is also a key strategic partner and investor in specialized venture funds like BioGeneration Ventures (BGV), which focuses on early-stage life sciences innovations, demonstrating a comprehensive approach to sector-specific investment.

For its direct growth and buyout investments, Mérieux Equity Partners typically deploys first cheques ranging from €10 million to €60 million. This range allows them to support companies at various stages of their growth trajectory, from scaling up operations to facilitating ownership transitions. The firm prides itself on being a long-term, value-added partner, providing not just capital but also strategic guidance, operational support, and access to its vast ecosystem within the healthcare and nutrition industries. Their commitment extends to fostering sustainable growth and innovation within their portfolio companies.